Peter Schellongowski

2.8k total citations
38 papers, 1.3k citations indexed

About

Peter Schellongowski is a scholar working on Epidemiology, Oncology and Hematology. According to data from OpenAlex, Peter Schellongowski has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Oncology and 11 papers in Hematology. Recurrent topics in Peter Schellongowski's work include Sepsis Diagnosis and Treatment (10 papers), Respiratory Support and Mechanisms (9 papers) and Neutropenia and Cancer Infections (9 papers). Peter Schellongowski is often cited by papers focused on Sepsis Diagnosis and Treatment (10 papers), Respiratory Support and Mechanisms (9 papers) and Neutropenia and Cancer Infections (9 papers). Peter Schellongowski collaborates with scholars based in Austria, Germany and France. Peter Schellongowski's co-authors include Thomas Staudinger, Valentin Fuhrmann, Gottfried Heinz, Christian Zauner, Philipp Wohlfarth, Ulrike Holzinger, Michael Trauner, Nikolaus Kneidinger, Andreas Drolz and Oliver Robak and has published in prestigious journals such as Blood, Hepatology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Peter Schellongowski

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Schellongowski Austria 16 634 272 262 238 199 38 1.3k
Natalia Polanco Spain 18 546 0.9× 148 0.5× 159 0.6× 285 1.2× 388 1.9× 62 1.6k
Stefano Busani Italy 20 557 0.9× 73 0.3× 473 1.8× 334 1.4× 235 1.2× 65 1.7k
Kirstine K. Søgaard Denmark 17 714 1.1× 616 2.3× 116 0.4× 409 1.7× 160 0.8× 68 1.6k
Tobias Lahmer Germany 22 426 0.7× 112 0.4× 270 1.0× 332 1.4× 488 2.5× 101 1.5k
Júlia Tizue Fukushima Brazil 22 377 0.6× 87 0.3× 310 1.2× 672 2.8× 69 0.3× 52 2.0k
Pavel Chalupa Czechia 11 806 1.3× 77 0.3× 149 0.6× 208 0.9× 138 0.7× 40 1.3k
Volker Kliem Germany 36 1.0k 1.6× 481 1.8× 611 2.3× 956 4.0× 235 1.2× 99 3.8k
Fabrizio Giostra Italy 19 634 1.0× 703 2.6× 269 1.0× 110 0.5× 84 0.4× 58 1.3k
Gíanni Biancofiore Italy 26 401 0.6× 935 3.4× 293 1.1× 1.5k 6.2× 123 0.6× 129 2.2k
F. Hémery France 21 466 0.7× 48 0.2× 381 1.5× 462 1.9× 135 0.7× 64 1.8k

Countries citing papers authored by Peter Schellongowski

Since Specialization
Citations

This map shows the geographic impact of Peter Schellongowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schellongowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schellongowski more than expected).

Fields of papers citing papers by Peter Schellongowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schellongowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schellongowski. The network helps show where Peter Schellongowski may publish in the future.

Co-authorship network of co-authors of Peter Schellongowski

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Schellongowski. A scholar is included among the top collaborators of Peter Schellongowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Schellongowski. Peter Schellongowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munshi, Laveena, Cristina Gutiérrez, Boris Böll, et al.. (2025). Contemporary review of critical illness following allogeneic hematopoietic stem cell transplant in adults. Intensive Care Medicine. 51(4). 742–755.
2.
Boeck, Lucas, Hans Pargger, Peter Schellongowski, et al.. (2023). Subjective and objective survival prediction in mechanically ventilated critically ill patients: a prospective cohort study. Critical Care. 27(1). 150–150. 1 indexed citations
3.
Lueck, Catherina, Philipp Wohlfarth, Michael Kiehl, et al.. (2022). Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplantation. 58(3). 303–310. 3 indexed citations
4.
Louw, Andry van de, Jordi Rello, Ignacio Martín‐Loeches, et al.. (2021). Bacteremia in critically ill immunocompromised patients with acute hypoxic respiratory failure: A post-hoc analysis of a prospective multicenter multinational cohort. Journal of Critical Care. 64. 114–119. 4 indexed citations
5.
Wohlfarth, Philipp, et al.. (2020). Hämatoonkologie und Intensivmedizin. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(8). 633–640.
6.
Kochanek, Matthias, Alexander Shimabukuro‐Vornhagen, Gernot Beutel, et al.. (2019). Prävalenz von Krebspatienten auf deutschen Intensivstationen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(4). 312–319. 8 indexed citations
7.
Schmidt, Matthieu, Peter Schellongowski, Nicolò Patroniti, et al.. (2018). Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. American Journal of Respiratory and Critical Care Medicine. 197(10). 1297–1307. 79 indexed citations
8.
Drolz, Andreas, Thomas Horvatits, Kevin Roedl, et al.. (2018). Acid–base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of Intensive Care. 8(1). 48–48. 24 indexed citations
9.
Schellongowski, Peter, et al.. (2016). Intensive care for cancer patients. memo - Magazine of European Medical Oncology. 9(1). 39–44. 11 indexed citations
10.
Schellongowski, Peter, Wolfgang R. Sperr, Philipp Wohlfarth, et al.. (2016). Critically ill patients with cancer: chances and limitations of intensive care medicine—a narrative review. ESMO Open. 1(5). e000018–e000018. 43 indexed citations
11.
12.
Drolz, Andreas, Thomas Horvatits, Kevin Roedl, et al.. (2014). Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. Journal of Hepatology. 60(6). 1187–1193. 25 indexed citations
13.
Schellongowski, Peter. (2013). Der hämatologisch-onkologische Patient auf der Intensivstation. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 108(3). 203–208. 6 indexed citations
14.
Schellongowski, Peter & Thomas Staudinger. (2012). Intensivmedizinische Probleme des hämatoonkologischen Patienten. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 107(5). 386–90. 1 indexed citations
15.
Jäger, Bernhard, Andreas Drolz, Peter Schellongowski, et al.. (2012). Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology. 56(6). 2297–2304. 60 indexed citations
16.
Vogl, Ursula, Kazuhiro Nagayama, Marija Bojić, et al.. (2012). Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation. 95(4). 623–628. 22 indexed citations
17.
Schellongowski, Peter, Thomas Staudinger, Michael Kundi, et al.. (2010). Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 96(2). 231–237. 90 indexed citations
18.
Zedtwitz‐Liebenstein, Konstantin, Péter Jaksch, Heinz Burgmann, et al.. (2009). Evaluation of interleukin‐6 and interleukin‐10 in lung transplant patients with human cytomegalovirus infection. Clinical Transplantation. 23(5). 687–691. 4 indexed citations
19.
Fuhrmann, Valentin, Nikolaus Kneidinger, Harald Herkner, et al.. (2009). Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Medicine. 35(8). 1397–1405. 155 indexed citations
20.
Schellongowski, Peter, Thomas Lang�, Christian Zauner, et al.. (2004). Comparison of three severity scores for critically ill cancer patients. Intensive Care Medicine. 30(3). 430–436. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Polanco Breakdown of academic impact, for papers by Stefano Busani Breakdown of academic impact, for papers by Kirstine K. Søgaard Breakdown of academic impact, for papers by Tobias Lahmer Breakdown of academic impact, for papers by Júlia Tizue Fukushima Breakdown of academic impact, for papers by Pavel Chalupa Breakdown of academic impact, for papers by Volker Kliem Breakdown of academic impact, for papers by Fabrizio Giostra Breakdown of academic impact, for papers by Gíanni Biancofiore Breakdown of academic impact, for papers by F. Hémery
Rankless by CCL
2026